HealthcareServices

Cognitive Diagnostics Market Outlook: Growth and Forecast Highlights 2030

February 23, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cognitive diagnostics market from 2026–2035 with trusted insights from The Business Research Company

How much is the Cognitive Diagnostics Market valued at in 2026, and what valuation is forecast for 2030?

The cognitive diagnostics market size has experienced remarkable growth in recent years. It is anticipated to expand from $6.25 billion in 2025 to $7.69 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.1%. This historical expansion can be linked to the increasing occurrence of neurodegenerative disorders, heightened awareness surrounding cognitive health, advancements in diagnostic imaging capabilities, a surge in the adoption of standardized cognitive tests, and the proliferation of neurology specialty clinics.

The cognitive diagnostics market is projected to experience substantial expansion in the coming years. By 2030, it is anticipated to reach a valuation of $17.46 billion, demonstrating a compound annual growth rate (CAGR) of 22.7%. This projected growth can be attributed to increased investments in digital diagnostics, a heightened demand for the early detection of cognitive disorders, the expansion of home-based cognitive assessment tools, a growing integration of AI in clinical decision support, and an increasing focus on personalized cognitive care. Major trends expected in this period include the rising use of AI-based cognitive assessment tools, wider adoption of digital cognitive screening platforms, greater deployment of neuroimaging analytics, the spread of remote cognitive testing solutions, and an enhanced emphasis on early disease detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19373&type=smp

What Drivers Are Influencing The Growth Of The Cognitive Diagnostics Market?

The increasing occurrence of neurological disorders is anticipated to drive expansion in the cognitive diagnostics market moving forward. These medical conditions impact the brain, spinal cord, and nervous system, hindering their normal operation and resulting in symptoms like impaired cognition, motor difficulties, and sensory issues. The growth in neurological disorders stems from a greater frequency of age-related ailments such as Alzheimer’s and Parkinson’s disease. Furthermore, genetic predispositions, coupled with environmental pollutants, stress, poor diets, and inactive lifestyles, contribute to the rising incidence of these disorders. Cognitive diagnostics serve to evaluate, identify, and track cognitive impairments within neurological diseases, facilitating prompt diagnosis and management of conditions like Alzheimer’s and Parkinson’s. For example, as reported by the Alzheimer’s Association, a U.S.-based nonprofit organization focused on Alzheimer’s care, support, and research, in May 2024, the count of Americans aged 65 and above diagnosed with Alzheimer’s dementia climbed from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising prevalence of neurological disorders is propelling the growth of the cognitive diagnostics market.

How Is The Cognitive Diagnostics Market Organized Into Various Segments?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

Which Competitive Trends Are Impacting The Structure Of The Cognitive Diagnostics Market?

Leading companies within the cognitive diagnostics market are prioritizing real-time insights into cognitive health by advancing diagnostic tools like neuropsychological testing platforms, aiming to improve the precision, speed, and thoroughness of cognitive evaluations. Neuropsychological testing platforms are dedicated digital instruments engineered to evaluate cognitive abilities such as memory, attention, and problem-solving skills via standardized assessments. An example of this trend occurred in April 2024, when BrainCheck Inc., a US-based digital health firm dedicated to advancing cognitive well-being, introduced its extensive digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting. This platform highlighted its sophisticated features for cognitive screening, evaluation, and care strategy development. Comprising Assess, Screen, and Plan modules, the platform provides clinicians with a contemporary method to simplify cognitive health management using mobile, digital technology that guarantees both accuracy and user-friendliness. This development is designed to boost the effectiveness and standard of care for both patients and healthcare providers through the provision of detailed, evidence-backed advice and complete care strategies.

Who Are The Major Companies Operating In The Cognitive Diagnostics Market?

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Cognitive Diagnostics Market?

North America was the largest region in the cognitive diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cognitive Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19373&type=smp

Browse Through More Reports Similar to the Global Cognitive Diagnostics Market 2026, By The Business Research Company

Cognitive Process Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-process-automation-global-market-report

Cognitive Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-services-global-market-report

Cognitive Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-analytics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795